• Home >
  • Vital Signs - Over the Patent Cliff: Suing the FDA is the Latest Action by Branded and Generics Pharmaceutical Companies Battling for Market Opportunity

Vital Signs - Over the Patent Cliff: Suing the FDA is the Latest Action by Branded and Generics Pharmaceutical Companies Battling for Market Opportunity

07-Mar-2013  /  Research Code: 9561-00-F3-00-00  /  SKU: LS00245-NA-MR_17659  /  
Region: North America

Regular Price: USD 1,500.00

Special Price USD 1,275.00

15% OFF

* Required Fields

Regular Price: USD 1,500.00

Special Price USD 1,275.00

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on March 7, 2013, provides an insight in to battle between FDA and branded and generic pharmaceutical companies. Additionally, a company spotlight is provided for PLC Diagnostics. PLC Diagnostics is an early stage startup, developing the next generation of handheld point-of-care testing devices.

Table of Contents

Vital Signs - Over the Patent Cliff: Suing the FDA is the Latest Action by Branded and Generics Pharmaceutical Companies Battling for Market OpportunityVital Signs: 7 March 2013This week's issue




Keyword1

Keyword2

Keyword3

Related Research

Endoscope Reprocessing Systems and Software Solutions Market Assessment, United States, Forecast to 2022

Release Date : 21-Jun-18

Region : North America

Assessment of the US Digital Dental Solutions Market, Forecast to 2020

Release Date : 19-Jun-18

Region : North America

Global Computed Tomography (CT) in Dimensional Metrology Market, Forecast to 2022

Release Date : 15-Jun-18

Region : North America

Global Animal Feed Phytogenics Market, Forecast to 2021

Release Date : 14-Jun-18

Region : North America

North American & South American Phytonutrient Ingredients Market, Forecast to 2022

Release Date : 14-Jun-18

Region : North America

Why Frost & Sullivan

Vision & Strategy

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Brand & Demand

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Technology & IP

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

Global Prespective

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.